Literature DB >> 15026258

Alterations in IGF-I, BDNF and NT-3 levels following experimental brain trauma and the effect of IGF-I administration.

Ilias Kazanis1, Margaret Giannakopoulou, Helen Philippidis, Fotini Stylianopoulou.   

Abstract

The effects of a unilateral, penetrating brain trauma on IGF-I, BDNF and NT-3 were studied immunocytochemically in the rat. BDNF and NT-3 were decreased in the peritraumatic area, but increased in the adjacent region, 4 and 12 h post-injury. One week following the trauma, BDNF remained low in the peritraumatic area, but was restored to normal levels in the adjacent, while no effect of injury on NT-3 levels was detected in either area. Injury resulted in an increase in IGF-I levels in the peritraumatic area, which was most pronounced 1 week following the trauma, indicating that IGF-I could participate in endogenous repair processes. We thus administered IGF-I immediately following the trauma and investigated its effects on injury-induced changes in neurotrophin levels. Administration of IGF-I partially reversed the injury-induced decrease in BDNF and NT-3 in the peritraumatic area observed 4 and 12 h post-injury, while at the same time-points, it completely cancelled the effects of injury in the adjacent region. One week after the trauma, BDNF levels were dramatically increased in both the peritraumatic and adjacent area, reaching levels even higher than those of the sham-operated animals, following IGF-I administration. Our results showing that IGF-I not only counteracts injury-induced changes in neurotrophins, but can also further increase their levels, indicate that this growth factor could mediate repair and/or protective processes, following brain trauma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026258     DOI: 10.1016/j.expneurol.2003.12.004

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  22 in total

Review 1.  A review of neuroprotection pharmacology and therapies in patients with acute traumatic brain injury.

Authors:  Kevin W McConeghy; Jimmi Hatton; Lindsey Hughes; Aaron M Cook
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

2.  Systemic Inflammation during the First Postnatal Month and the Risk of Attention Deficit Hyperactivity Disorder Characteristics among 10 year-old Children Born Extremely Preterm.

Authors:  Elizabeth N Allred; Olaf Dammann; Raina N Fichorova; Stephen R Hooper; Scott J Hunter; Robert M Joseph; Karl Kuban; Alan Leviton; Thomas Michael O'Shea; Megan N Scott
Journal:  J Neuroimmune Pharmacol       Date:  2017-04-12       Impact factor: 4.147

3.  Circulating biomarkers in extremely preterm infants associated with ultrasound indicators of brain damage.

Authors:  Alan Leviton; Elizabeth N Allred; Raina N Fichorova; T Michael O'Shea; Lynn A Fordham; Karl K C Kuban; Olaf Dammann
Journal:  Eur J Paediatr Neurol       Date:  2018-01-31       Impact factor: 3.140

Review 4.  Astrocyte-derived growth factors and estrogen neuroprotection: role of transforming growth factor-α in estrogen-induced upregulation of glutamate transporters in astrocytes.

Authors:  Pratap Karki; Keisha Smith; James Johnson; Eunsook Lee
Journal:  Mol Cell Endocrinol       Date:  2014-01-18       Impact factor: 4.102

5.  Angiotensin II Receptor Blockers Attenuate Lipopolysaccharide-Induced Memory Impairment by Modulation of NF-κB-Mediated BDNF/CREB Expression and Apoptosis in Spontaneously Hypertensive Rats.

Authors:  Ruby Goel; Shahnawaz Ali Bhat; Kashif Hanif; Chandishwar Nath; Rakesh Shukla
Journal:  Mol Neurobiol       Date:  2017-02-18       Impact factor: 5.590

6.  Subventricular zone-derived neural stem cell grafts protect against hippocampal degeneration and restore cognitive function in the mouse following intrahippocampal kainic acid administration.

Authors:  Panagiota Miltiadous; Georgia Kouroupi; Antonios Stamatakis; Paraskevi N Koutsoudaki; Rebecca Matsas; Fotini Stylianopoulou
Journal:  Stem Cells Transl Med       Date:  2013-02-15       Impact factor: 6.940

7.  Evidence of Abeta- and transgene-dependent defects in ERK-CREB signaling in Alzheimer's models.

Authors:  Qiu-Lan Ma; Marni E Harris-White; Oliver J Ubeda; Mychica Simmons; Walter Beech; Giselle P Lim; Bruce Teter; Sally A Frautschy; Greg M Cole
Journal:  J Neurochem       Date:  2007-08-30       Impact factor: 5.372

8.  Neuroprotective effects of IGF-I following kainic acid-induced hippocampal degeneration in the rat.

Authors:  Panagiota Miltiadous; Antonios Stamatakis; Fotini Stylianopoulou
Journal:  Cell Mol Neurobiol       Date:  2009-09-24       Impact factor: 5.046

9.  Reductions in qEEG slowing over 1 year and after treatment with Cerebrolysin in patients with moderate-severe traumatic brain injury.

Authors:  X Antón Alvarez; Carolina Sampedro; Jesús Figueroa; Iván Tellado; Andrés González; Manuel García-Fantini; Ramón Cacabelos; Dafin Muresanu; Herbert Moessler
Journal:  J Neural Transm (Vienna)       Date:  2008-02-14       Impact factor: 3.575

10.  Temporal and regional changes in IGF-1/IGF-1R signaling in the mouse brain after traumatic brain injury.

Authors:  Sindhu Kizhakke Madathil; Heather N Evans; Kathryn E Saatman
Journal:  J Neurotrauma       Date:  2010-01       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.